+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Postoperative Fractionated Stereotactic Radiosurgery to the Tumor Bed for Surgically Resected Brain Metastases



Postoperative Fractionated Stereotactic Radiosurgery to the Tumor Bed for Surgically Resected Brain Metastases



Cureus 9(5): E1279



Introduction Stereotactic radiosurgery (SRS) is increasingly used as an alternative to whole brain radiotherapy (WBRT) following surgical resection of brain metastases. We analyzed the outcomes of postoperative frameless fractionated stereotactic radiosurgery (fSRS) cases for surgically resected brain metastases at our institution. Materials and Methods We performed a retrospective review of 85 patients who underwent fSRS to 87 resection beds from 2006 - 2014 with a median follow-up of 6.4 months. Clinically relevant outcomes were assessed with analysis to determine predictors of these outcomes. Results The median target volume was 9.8 cm-3 (1.1 - 43.1 cm-3). The most frequently used fractionation scheme was 3,000 cGy in five fractions. The rates of local control (LC), distant brain failure (DBF), and overall survival (OS) at one-year were 87%, 52%, and 52%, respectively. Five patients (5.9%) experienced Grade >2 toxicity related to fSRS, including seizures (two), symptomatic radionecrosis (two), and potential treatment-related death (one). A multivariable analysis revealed that tumor volume (p < 0.001) and number of fractions (p < 0.001) were associated with LC, while recursive partitioning analysis (RPA) class (< .0001), tumor volume (= .0181), and the number of fractions (p = .0181) were associated with OS. Conclusions Postoperative fSRS for surgically resected brain metastases is well-tolerated and achieves durable LC. Further studies are needed to determine the optimal dose and fractionation for fSRS as well as to compare outcomes with WBRT.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 060109968

Download citation: RISBibTeXText

PMID: 28656127


Related references

Tumor Cavity Recurrence after Stereotactic Radiosurgery of Surgically Resected Brain Metastases: Implication of Deviations from Contouring Guidelines. Stereotactic and Functional Neurosurgery 97(1): 24-30, 2019

Postoperative stereotactic radiosurgery for patients with resected brain metastases: a volumetric analysis. Journal of Neuro-Oncology 140(2): 395-401, 2018

Consensus Contouring Guidelines for Postoperative Completely Resected Cavity Stereotactic Radiosurgery for Brain Metastases. International Journal of Radiation Oncology Biology Physics 100(2): 436-442, 2018

Postoperative stereotactic radiosurgery for resected brain metastases: A comparison of outcomes for large resection cavities. Practical Radiation Oncology 7(6): E419-E425, 2017

Comparison of Fractionated Stereotactic Radiosurgery and Single-Fraction Stereotactic Radiosurgery for the Treatment of Brain Metastases. International Journal of Radiation Oncology*biology*physics 90(1): S319-S320, 2014

Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC). Lung Cancer 132: 119-125, 2019

Fractionated stereotactic radiosurgery for locally recurrent brain metastases after failed stereotactic radiosurgery. Indian Journal of Cancer 56(2): 151-156, 2019

Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases. Journal of Neurosurgery 130(3): 797-803, 2018

Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases. Journal of Neuro-Oncology 132(3): 455-462, 2017

Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases. Journal of Neuro-Oncology 109(1): 91-98, 2012

Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size. International Journal of Radiation Oncology Biology Physics 85(3): 650-655, 2013

A statistical comparison of prognostic index systems for brain metastases after stereotactic radiosurgery or fractionated stereotactic radiation therapy. Clinical Oncology ) 25(4): 227-235, 2013

Predicting the Risk of Developing New Cerebral Lesions After Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastases from Renal Cell Carcinoma. Anticancer Research 38(5): 2973-2976, 2018

Fractionated stereotactic radiosurgery for large brain metastases. American Journal of Clinical Oncology 38(2): 135-139, 2015

Fractionated stereotactic radiosurgery for patients with brain metastases. Journal of Neuro-Oncology 117(2): 295-301, 2014